How should I evaluate and manage a patient with a low red blood cell count (3.74 million/µL) and mildly low hematocrit (36%)?

Evaluation and Management of Low RBC and Hematocrit

Order a complete blood count with indices (MCV, MCH, RDW) and reticulocyte count immediately, then measure serum ferritin and transferrin saturation to determine if this represents iron deficiency, chronic disease, or another etiology requiring specific intervention.

Initial Diagnostic Approach

The values you've presented (RBC 3.74 million/µL, Hct 36%) indicate mild anemia that requires systematic evaluation. Hemoglobin measurement is preferred over hematocrit for ongoing assessment because it's more reproducible across laboratories and isn't affected by storage time or patient variables like serum glucose 1.

Essential First-Line Testing

A complete blood count examining all three cell lines (WBC, hemoglobin, platelets) is mandatory to assess bone marrow function 1. This is critical because:

• Abnormalities in two or more cell lines warrant hematology consultation 1
• Low mean corpuscular volume (MCV) suggests iron deficiency, folate/B12 deficiency, or inherited hemoglobin synthesis disorders 1
• The reticulocyte count (absolute or index) evaluates whether the bone marrow is responding appropriately to the anemia 1

Iron Studies Are Critical

Measure serum ferritin and transferrin saturation as part of your initial workup 1. Iron deficiency is the most common treatable cause of anemia:

• Serum ferritin reflects tissue iron stores
• Transferrin saturation indicates iron available for erythropoiesis and is less affected by inflammation than ferritin 1
• In non-dialysis patients, ferritin <25 ng/mL (males) or <11 ng/mL (females) predicts insufficient iron stores 1

Context-Specific Considerations

Before attributing this anemia to a single cause, consider patient-specific factors that affect normal ranges 1:

• Pregnancy or menstruating women (physiologic hemodilution in pregnancy makes Hb <11.0 g/dL in first trimester or <10.5 g/dL in second/third trimester diagnostic 2)
• Age ≥70 years in men
• Non-Caucasian race
• High altitude living
• Smoking status
• Chronic lung disease
• Hemoglobinopathy carriers

Red Flags Requiring Further Investigation

If iron deficiency is confirmed in a patient without menstrual losses or known iron loss, carefully assess for gastrointestinal bleeding 1. This is a critical pitfall—occult GI bleeding is commonly missed.

Treatment Principles

Once you've identified the cause:

• For confirmed iron deficiency: Oral iron is first-line treatment; recent evidence supports intermittent dosing (as effective as daily with fewer side effects) 2
• For oral iron intolerance/malabsorption/non-response: Intravenous iron is preferred with contemporary formulations having rare allergic reactions 3, 2
• For anemia of chronic disease with functional iron deficiency: IV iron is generally the treatment of choice in complex medical patients 3

Common Pitfalls to Avoid

1. Don't rely on hematocrit alone—it's less reliable than hemoglobin for diagnosis and monitoring 1
2. Don't assume CKD is the cause if kidney disease is present—patients may have multiple contributing factors 1
3. Don't miss thalassemia trait—carriers are often asymptomatic with mild microcytosis and may have normal or near-normal hemoglobin 4
4. Don't overlook elevated hemoglobin with erythrocytosis—this pattern suggests hereditary hemochromatosis rather than thalassemia trait, regardless of low MCV 5

The systematic approach outlined above prioritizes identifying treatable causes (particularly iron deficiency) while avoiding premature closure on a single diagnosis before completing the essential workup.